Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-10-28 Sale |
2022-11-01 7:55 pm |
Paratek Pharmaceuticals Inc. | PRTK | Haskel William M. CLO, General Counsel & Sec. |
4,382 | $3.47 | $15,206 | 437,801 (Direct) |
View |
2022-10-28 Sale |
2022-11-01 7:53 pm |
Paratek Pharmaceuticals Inc. | PRTK | Brenner Randall B. Chief Development & Regulatory |
3,516 | $3.47 | $12,201 | 354,133 (Direct) |
View |
2022-10-28 Sale |
2022-11-01 7:51 pm |
Paratek Pharmaceuticals Inc. | PRTK | BIGHAM MICHAEL Exec. Chairman of the Board |
6,000 | $3.47 | $20,820 | 1,231,827 (Direct) |
View |
2022-08-09 Sale |
2022-08-10 9:06 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
44,519 | $2.66 | $118,421 | 1,257,742 (Direct) |
View |
2022-08-09 Sale |
2022-08-10 9:04 pm |
Paratek Pharmaceuticals Inc. | PRTK | Haskel William M. CLO, General Counsel & Sec. |
22,453 | $2.66 | $59,725 | 432,933 (Direct) |
View |
2022-08-09 Sale |
2022-08-10 9:02 pm |
Paratek Pharmaceuticals Inc. | PRTK | Brenner Randall B. Chief Development & Regulatory |
19,608 | $2.66 | $52,157 | 349,149 (Direct) |
View |
2022-08-09 Sale |
2022-08-10 9:00 pm |
Paratek Pharmaceuticals Inc. | PRTK | BIGHAM MICHAEL Exec. Chairman of the Board |
28,637 | $2.66 | $76,174 | 1,207,827 (Direct) |
View |
2021-12-13 Sale |
2021-12-15 9:02 pm |
Paratek Pharmaceuticals Inc. | PRTK | BIGHAM MICHAEL Exec. Chairman of the Board |
31,500 | $4.3215 | $136,126 | 890,782 (Direct) |
View |
2021-12-13 Sale |
2021-12-15 8:57 pm |
Paratek Pharmaceuticals Inc. | PRTK | Brenner Randall B. Chief Development & Regulatory |
27,894 | $4.3215 | $120,543 | 253,530 (Direct) |
View |
2021-12-13 Sale |
2021-12-15 8:50 pm |
Paratek Pharmaceuticals Inc. | PRTK | Haskel William M. CLO, General Counsel & Sec. |
30,366 | $4.3215 | $131,225 | 340,159 (Direct) |
View |
2021-12-13 Sale |
2021-12-15 8:45 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
87,076 | $4.3215 | $376,295 | 913,284 (Direct) |
View |
2021-12-13 Sale |
2021-12-15 8:37 pm |
Paratek Pharmaceuticals Inc. | PRTK | Woodrow Adam President & Chief Commercial |
39,992 | $4.3215 | $172,824 | 462,329 (Direct) |
View |
2021-08-17 Sale |
2021-08-18 7:29 pm |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
33,931 | $5.12 | $173,727 | 1,000,360 (Direct) |
View |
2021-08-17 Sale |
2021-08-18 7:22 pm |
Paratek Pharmaceuticals Inc. | PRTK | Haskel William M. CLO, General Counsel & Sec. |
9,692 | $5.12 | $49,623 | 370,525 (Direct) |
View |
2021-08-17 Sale |
2021-08-18 7:16 pm |
Paratek Pharmaceuticals Inc. | PRTK | BIGHAM MICHAEL Exec. Chairman of the Board |
32,030 | $5.12 | $163,994 | 922,282 (Direct) |
View |
2021-08-17 Sale |
2021-08-18 7:14 pm |
Paratek Pharmaceuticals Inc. | PRTK | Brenner Randall B. Chief Development & Regulatory |
8,766 | $5.12 | $44,882 | 281,424 (Direct) |
View |
2021-08-17 Sale |
2021-08-18 7:11 pm |
Paratek Pharmaceuticals Inc. | PRTK | Woodrow Adam President & Chief Commercial |
10,975 | $5.12 | $56,192 | 501,321 (Direct) |
View |
2021-06-04 Sale |
2021-06-08 7:34 pm |
Paratek Pharmaceuticals Inc. | PRTK | Woodrow Adam President & Chief Commercial |
17,182 | $9.7 | $166,665 | 474,796 (Direct) |
View |
2021-06-04 Sale |
2021-06-08 7:32 pm |
Paratek Pharmaceuticals Inc. | PRTK | Haskel William M. CLO, General Counsel & Sec. |
7,561 | $9.7 | $73,342 | 357,092 (Direct) |
View |
2021-06-04 Sale |
2021-06-08 7:30 pm |
Paratek Pharmaceuticals Inc. | PRTK | Brenner Randall B. Chief Development & Regulatory |
9,978 | $9.7 | $96,787 | 268,940 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-10-25 Option Award |
2022-10-27 7:08 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Woodrow Adam President & Chief Commercial |
15,000 | $0 | 650,170 (Direct) |
View |
2022-10-25 Option Award |
2022-10-27 7:06 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
30,000 | $0 | 1,287,742 (Direct) |
View |
2022-10-25 Option Award |
2022-10-27 7:04 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Haskel William M. CLO, General Counsel & Sec. |
9,250 | $0 | 442,183 (Direct) |
View |
2022-10-25 Option Award |
2022-10-27 7:03 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Brenner Randall B. Chief Development & Regulatory |
8,500 | $0 | 357,649 (Direct) |
View |
2022-10-25 Option Award |
2022-10-27 7:00 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | BIGHAM MICHAEL Exec. Chairman of the Board |
30,000 | $0 | 1,237,827 (Direct) |
View |
2022-08-08 Option Award |
2022-08-10 9:08 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Woodrow Adam President & Chief Commercial |
71,591 | $0 | 635,170 (Direct) |
View |
2022-08-08 Option Award |
2022-08-10 9:06 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
152,727 | $0 | 1,257,742 (Direct) |
View |
2022-08-08 Option Award |
2022-08-10 9:04 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Haskel William M. CLO, General Counsel & Sec. |
47,727 | $0 | 432,933 (Direct) |
View |
2022-08-08 Option Award |
2022-08-10 9:02 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Brenner Randall B. Chief Development & Regulatory |
47,727 | $0 | 349,149 (Direct) |
View |
2022-08-08 Option Award |
2022-08-10 9:00 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | BIGHAM MICHAEL Exec. Chairman of the Board |
143,182 | $0 | 1,207,827 (Direct) |
View |
2022-03-15 Option Award |
2022-03-23 8:45 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Woodrow Adam President & Chief Commercial |
101,250 | $0 | 563,579 (Direct) |
View |
2022-03-15 Option Award |
2022-03-23 8:41 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
236,250 | $0 | 1,149,534 (Direct) |
View |
2022-03-15 Option Award |
2022-03-23 8:37 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Haskel William M. CLO, General Counsel & Sec. |
67,500 | $0 | 407,659 (Direct) |
View |
2022-03-15 Option Award |
2022-03-23 8:33 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Brenner Randall B. Chief Development & Regulatory |
67,500 | $0 | 321,030 (Direct) |
View |
2022-03-15 Option Award |
2022-03-23 8:28 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | BIGHAM MICHAEL Exec. Chairman of the Board |
202,500 | $0 | 1,093,282 (Direct) |
View |
2022-02-16 Option Award |
2022-02-18 5:35 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Stein Jeffrey Director |
20,000 | $0 | 55,625 (Direct) |
View |
2022-02-16 Option Award |
2022-02-18 5:31 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Radie Robert S Director |
20,000 | $0 | 52,250 (Direct) |
View |
2022-02-16 Option Award |
2022-02-18 5:27 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Peterson Kristine Director |
20,000 | $0 | 59,000 (Direct) |
View |
2022-02-16 Option Award |
2022-02-18 5:23 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Hoffmann Rolf K Director |
20,000 | $0 | 64,000 (Direct) |
View |
2022-02-16 Option Award |
2022-02-18 5:18 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Franson Timothy R Director |
20,000 | $0 | 59,000 (Direct) |
View |
2022-02-16 Option Award |
2022-02-18 5:14 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Dietz Thomas John Director |
20,000 | $0 | 50,000 (Direct) |
View |
2022-02-16 Option Award |
2022-02-18 5:09 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Baylor-Henry Minnie Director |
20,000 | $0 | 39,200 (Direct) |
View |
2021-08-16 Option Award |
2021-08-18 7:29 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Loh Evan CEO |
75,000 | $0 | 1,000,360 (Direct) |
View |
2021-08-16 Option Award |
2021-08-18 7:22 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Haskel William M. CLO, General Counsel & Sec. |
23,125 | $0 | 370,525 (Direct) |
View |
2021-08-16 Option Award |
2021-08-18 7:16 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | BIGHAM MICHAEL Exec. Chairman of the Board |
75,000 | $0 | 922,282 (Direct) |
View |
2021-08-16 Option Award |
2021-08-18 7:14 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Brenner Randall B. Chief Development & Regulatory |
21,250 | $0 | 281,424 (Direct) |
View |
2021-08-16 Option Award |
2021-08-18 7:11 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Woodrow Adam President & Chief Commercial |
37,500 | $0 | 501,321 (Direct) |
View |
2021-06-30 Option Award |
2021-07-01 4:23 pm |
N/A 2031-06-30 |
Paratek Pharmaceuticals Inc. | PRTK | Baylor-Henry Minnie Director |
32,000 | $0 | 32,000 (Direct) |
View |
2021-05-27 Option Award |
2021-06-08 7:34 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Woodrow Adam President & Chief Commercial |
42,955 | $0 | 474,796 (Direct) |
View |
2021-05-27 Option Award |
2021-06-08 7:32 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Haskel William M. CLO, General Counsel & Sec. |
28,636 | $0 | 357,092 (Direct) |
View |
2021-05-27 Option Award |
2021-06-08 7:30 pm |
N/A N/A |
Paratek Pharmaceuticals Inc. | PRTK | Brenner Randall B. Chief Development & Regulatory |
28,636 | $0 | 268,940 (Direct) |
View |